Fleur Abas

Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT.

N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.

Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Standard Investment Management BV (Standard Investment) is a private equity firm founded in 2004 by Idgar van Kippersluis and Hendrik Jan ten Have. The firm is headquartered in Amsterdam, the Netherlands with additional offices in Etterbeek, Belgium and Stockholm, Sweden.

Organon Pharmaceutical USA, Inc. markets and distributes pharmaceutical products. Its products include contraceptives and anesthetics, as well as treatments for mental health disorders. The company is headquartered in Roseland, NJ.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

BarentsKrans NV operates as a law firm. The company specializes in litigation, intellectual property, and labor law. The company also offers services in the fields of corporate and financial litigation, corporate M&A, real estate, life sciences, and financial services. The company was founded in 1995 and is headquartered in The Hague, the Netherlands.

Part of Stichting Administratiekantoor Liftinstituut Holding, Liftinstituut Holding BV is a Dutch company that provides professional development training services and installs lift & elevator systems. The company is based in Amsterdam, Netherlands. The company was founded in 1933. The CEO is John van Vliet.

DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands.

Media Development Investment Fund provides financing and technical assistance to independent news and information businesses. The firm invests in media that provide the news, information and debate that people need to build free, thriving societies. The company was founded by Sasa Vucinic and Stuart Auerbach in 1995 and is headquartered in New York, NY.

2theloo Holding BV owns and operates toilet stores. The firm operates restrooms and washrooms in city centers, shopping centers, and train and gas stations in Europe. It also provides various other services, such as shops with toiletry-related products, gifts and gadgets, and coffee corners. The company was founded by Eric Treurniet and Almar Holtz in 2011 and is headquartered in Amsterdam, the Netherlands.

4 Catalyzer Corporation (4 Catalyzer Corp.) is a venture capital firm founded in 2014 by Jonathan M. Rothberg. The firm is headquartered in Guilford, Connecticut.

Shypple BV develops platform to search, book, manage, track and analyze freight forwarding. The company was founded by Jarell Habets in 2016 and is headquartered in Rotterdam, the Netherlands.

Vintage Trading Solutions Ltd. operates as an online portal that engages in selling your old unused vintage items. The company was founded by David Anthony Weaver and Antony Charman and is headquartered in Leeds, the United Kingdom.

Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.

Pluralis BV invests in news companies. The private company is located in Netherlands.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.

NRC Media Holding BV operates as a financial holding company with interests in newspaper publishing services. The company is headquartered in Amsterdam, the Netherlands.

Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands.